Epigenetic Modulators and the New Immunotherapies

The recent arrival of the immune-checkpoint–inhibitor drugs — first applied to melanoma and more recently tested as a treatment for different solid tumors and hematologic cancers — has changed the management of these conditions. The response rates have been impressive, as have the…

from Cancer via ola Kala on Inoreader http://ift.tt/1QnxpLV
via IFTTT